2023 Outlook: Holistic Approach, Competitive Benefits Are Keys to Success in MA
January 19
With upcoming changes to marketing regulations, the Star Ratings program, and various other aspects of Medicare Advantage — combined with ongoing scrutiny of MA plan payments and a pending rule that could significantly boost the federal government’s collection of overpayments through Risk Adjustment Data Validation audits — achieving success in MA continues to be a balancing act. For our annual series of Outlook stories on the year ahead, we asked a range of industry experts to weigh in on how doing business in 2023 might differ from previous years. Here’s the second installment, on the investments and strategies that will drive success in 2023, as told to AIS Health, a division of MMIT.
© 2023 MMIT
Meet Our Reporters
-
Angela Maas Managing Editor, RADAR on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and RADAR on Drug Benefits
View Leslie Small's Profile -
Lauren Flynn Kelly Managing Editor, RADAR on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Peter Johnson Reporter, Health Plan Weekly and RADAR on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and RADAR on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, RADAR on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and RADAR on Drug Benefits
View Jinghong Chen's Profile -
Jill Brown Kettler Executive Editor
View Jill Brown Kettler's Profile
